Biogen Inc. buy Royal Bank of Canada
Start price
29.05.24
/
50%
€195.00
Target price
29.05.25
€292.88
Performance (%)
-39.85%
End price
30.05.25
€117.30
Summary
This prediction ended on 30.05.25 with a price of €117.30. Massive losses of -39.85% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 4.976% | 4.976% | 65.471% |
| iShares Core DAX® | -1,09 % | 0,20 % | 2,09 % |
| iShares Nasdaq 100 | -2,46 % | -1,79 % | 29,25 % |
| iShares Nikkei 225® | -5,37 % | -5,43 % | 54,33 % |
| iShares S&P 500 | -0,20 % | 1,77 % | 23,58 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $317.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten